Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Health Review.
Press releases published on April 15, 2025
Flottweg Features Separation Solutions for Pharmaceutical, Chemical & Fermentation Processes
EIN Presswire
·
April 15, 2025
Visit Flottweg at the Powder …
Lucia Magnani Health Clinic Earns Two Major 2025 Wellness Awards
EIN Presswire
·
April 15, 2025
MILAN, MILAN, ITALY, April 15, 2025 /EINPresswire.com/ -- The Lucia Magnani Health Clinic has been awarded Best Medical SPA 2025 at the Italian SPA Awards 2025 and listed among the most iconic SPAs of 2025 by the prestigious international guide Condé …
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
GlobeNewswire
·
April 15, 2025
All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for re-election confirmed Dividend of CHF 0.60 per registered dividend-paying share approved, representing 24% of …
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
GlobeNewswire
·
April 15, 2025
Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a €21.5 million financing round with …
1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research
GlobeNewswire
·
April 15, 2025
Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics, Inc. (1STBIO), a clinical-stage biopharmaceutical …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 15, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific …